<DOC>
	<DOCNO>NCT00186810</DOCNO>
	<brief_summary>This protocol study effect administration myeloablative pretransplant preparative regimen follow infusion donor stem cell child severe sickle cell disease . The donor graft consist bone marrow cord blood derive genetically match sibling . The primary aim study evaluate well donate cell migrate bone marrow begin produce healthy red blood cell , white blood cell platelet ( engraft ) , well recipient immune system recover , assess regimen related toxicity include potentially life-threatening transplant relate complication call graft-versus-host-disease GVHD .</brief_summary>
	<brief_title>Stem Cell Transplantation With Identical Donors Patients With Sickle Cell Disease</brief_title>
	<detailed_description>The secondary objective protocol evaluate effect transplant procedure subsequent clinical course patient severe SCD . Specifically , determine whether pre-transplant organ dysfunction ( brain , heart , lung , kidney , liver , spleen , etc ) resultant sickle hemoglobinopathy reverse follow particular transplant procedure .</detailed_description>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<criteria>Inclusion criterion : Diagnosis severe ' disease denote one following : Previous central nervous system vasoocclusive episode without residual neurologic finding Frequent painful vasoocclusive episode significant interference normal life activity necessitate chronic transfusion therapy Recurrent SCD chest syndrome event necessitate chronic transfusion therapy . Exclusion criterion : Patient SCD chronic lung disease great equal stage 3 Patient severe renal dysfunction define creatinine clearance &lt; 40 ml/min/1.73m2 . Patient severe cardiac dysfunction define echocardiogram shorten fraction &lt; 25 % . Patient HIV infection . Pregnant lactating . Patient unspecified chronic toxicity opinion Principal Investigator serious enough detrimentally affect patient 's capacity tolerate SCT . Patient patient 's guardian ( ) unable understand nature risk inherent BMT process</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Sickle Cell</keyword>
</DOC>